Abstract
This study anonymously examined 2,734 psychiatric patients worldwide for worsening of their pre-existing psychiatric condition during the COVID-19 pandemic. Valid responses mainly from 12 featured countries indicated self-reported worsening of psychiatric conditions in 2/3rd of the patients assessed that was validated through their significantly higher scores on scales for general psychological disturbance, post-traumatic stress disorder, and depression. Female gender, feeling no control of the situation and reporting dissatisfaction with the response of the state during the COVID-19 pandemic, and reduced interaction with family and friends increased the worsening of pre-existing psychiatric conditions, whereas optimism, ability to share concerns with family and friends and using social media like usual were associated with less worsening. An independent clinical investigation from the USA confirmed worsening of psychiatric conditions during the COVID-19 pandemic based on identification of new symptoms that necessiated clinical interventions such as dose adjustment or starting new medications in more than half of the patients.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
This study doesn't include any clinical trial.
Funding Statement
The authors worked voluntarily for this project and have no funding source to disclose. AJ is supported by an International Research Agenda (MAB) grant by Foundation for Polish Science (FNP).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Informed consent was obtained from each survey and clinical participant to allow anonymous recording, analysis, and publication of their answers. The data was collected in a completely anonymous fashion without recording any personal identifiers and the confidentiality of the participants was maintained throughout all phases of the study. The study procedures were reviewed and approved by University of Zurich Research Office for Scientific Integrity and Cantonal Ethics Commission for the canton of Zurich (Switzerland), Nencki Institute of Experimental Biology, Warsaw (Poland), and the Faculty of Medicine, University of Tuzla, Tuzla (Bosnia and Herzegovina)
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data presented in the main and supplementary items are deposited on the repository below and are available for verification upon request.
https://osf.io/3vupe/?view_only=80f71b6f0c8d49b08573ea12eab10d33
